- Company Information
- Fastest-growing Companies
- Updated:10/21/26
- Country/Territory:U.S.
- Headquarters:San Diego
- Industry:Pharmaceuticals
- CEO:Helen I. Torley
- Website:https://halozyme.com
- Ticker:HALO
- Company type:Public
- Revenues ($M):$1,509
- Profits ($M):$349
- Market value ($M):$12,530
- Number of employees:423
Figures are for latest twelve months ended on or before April 30, 2026. Market value as of Sept. 30, 2026.
- Revenue 3 Yr Growth Rank:38
- Revenue 3 Yr Annual Growth Rate:28.9%
- EPS 3 Yr Growth Rank:82
- EPS 3 Yr Annual Growth Rate:29.7%
- Total Return 3 Yr Rank:69
- Total Return 3 Yr Annual Rate:29.4%
- Beat S&P 500 3 Yr Return:yes
- Current Streak:1
- Years on List:2
- Sector:Health Care
Total return for the period ended June 30, 2026.
Halozyme Therapeutics stock chart
Halozyme Therapeutics in Fortune Rankings
- 100 Fastest-Growing Companies